text
"['\n1. 요약재무정보\n가. 개별 재무정보\n1) 요약재무정보(개별)\xa0\n(단위 : 원 )\n구 분\n제67기 1분기\n제66기\n제65기\n[유동자산]\n54,101,703,727\n49,249,571,579\n70,498,286,259\nㆍ당좌자산\n48,447,505,168\n44,005,004,881\n66,146,502,267\nㆍ재고자산\n5,654,198,559\n5,244,566,698\n4,351,783,992\n[비유동자산]\n28,937,403,213\n31,800,648,488\n34,453,722,262\nㆍ투자자산\n7,622,942,696\n5,252,954,039\n7,072,214,209\nㆍ유형자산\n14,383,901,050\n14,971,872,727\n16,812,222,383\nㆍ무형자산\n277,187,555\n276,996,396\n470,440,456\nㆍ기타비유동자산\n6,653,371,912\n11,298,825,326\n10,098,845,214\n자산총계\n83,039,106,940\n81,050,220,067\n104,952,008,521\n[유동부채]\n3,168,503,858\n3,892,299,448\n13,644,112,827\n[비유동부채]\n5,818,900,682\n5,765,562,485\n8,120,158,181\n부채총계\n8,987,404,540\n9,657,861,933\n21,764,271,008\n[지배기업의 소유주에게 귀속되는 자본]\n74,051,702,400\n71,392,358,134\n83,187,737,513\nㆍ자본금\n59,291,502,500\n59,291,502,500\n59,291,502,500\nㆍ자본잉여금\n9,530,092,969\n9,530,092,969\n9,530,092,969\nㆍ기타자본항목\n454,045,296\n135,872,342\n140,986,653\nㆍ이익잉여금(결손금)\n4,776,061,635\n2,434,890,323\n14,225,155,391\n[비지배지분]\n-\n-\n-\n자본총계\n74,051,702,400\n71,392,358,134\n83,187,737,513\n2023.4.1~2023.6.30\n2022.4.1~2023.3.31\n2021.4.1~2022.3.31\n매출액\n7,021,771,916\n28,819,028,142\n26,276,462,476\n영업이익(손실)\n690,099,406\n1,452,807,025\n(3,780,753,830)\n법인세비용차감전순이익(손실)\n2,225,444,051\n(12,590,731,832)\n(3,361,205,253)\n당기순이익(손실)\n2,316,563,096\n(12,423,707,818)\n34,198,169,452\n\xa0 \xa0계속영업당기순이익\n2,316,563,096\n(12,423,707,818)\n(3,430,330,177)\n\xa0 \xa0중단영업당기순이익\n-\n-\n37,628,499,629\n기본주당이익\n20\n(105)\n288\n\xa0 \xa0계속영업기본주당이익\n20\n(105)\n(29)\n\xa0 \xa0중단영업기본주당이익\n-\n-\n317\n희석주당이익\n20\n(105)\n288\n\xa0 \xa0 계속영업희석주당이익\n20\n(105)\n(29)\n\xa0 \xa0 중단영업희석주당이익\n-\n-\n317\n연결에 포함된 회사수 \xa0 (단위 : 개)\n-\n-\n-\n※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다.\n2) 재무제표 재작성-해당사항 없음.\n3) 당기에 신규로 연결재무제표에 포함된 종속기업이나 당기 중 연결재무제표의 작성대상에서 제외된 종속기업은 다음과 같습니다.\xa0\n회계기준\n제67기\n제66기\n제65기\n한국채택국제회계기준(K-IFRS)적용 시\n-\n-\n연결제외ORIENT SCIENCE & HEALTHCARE, INC.Orient Bioresource Center Inc\n4) 연결재무제표 작성 기준-해당사항 없음.\n']"
